Platelet inhibitor therapy for patients with cardiovascular disease: looking toward the future.

Wael A. Aljaroudi, Abdul R. Halabi, Robert A. Harrington

Research output: Contribution to journalReview articlepeer-review

7 Scopus citations

Abstract

Understanding platelet function and the role of platelets in the response to vascular injury has led to the development of novel platelet-inhibiting therapies that have been proven effective in the treatment of acute and chronic vascular disease. Antiplatelet therapies are cornerstone treatments for patients with acute coronary syndromes and have been essential in reducing the acute and subacute ischemic complications of percutaneous coronary intervention. Furthermore, an increased understanding of the pathobiology behind the platelet's role in atherothrombosis has offered up many new avenues of research and many new targets for therapeutic drug development. This review briefly summarizes the state of available anticoagulant and antiplatelet treatments in cardiovascular disease management and provides a perspective on the key issues in developing new antiplatelet strategies in the future.

Original languageEnglish (US)
Pages (from-to)397-404
Number of pages8
JournalCurrent hematology reports
Volume4
Issue number5
StatePublished - Sep 2005
Externally publishedYes

ASJC Scopus subject areas

  • Hematology

Fingerprint Dive into the research topics of 'Platelet inhibitor therapy for patients with cardiovascular disease: looking toward the future.'. Together they form a unique fingerprint.

Cite this